FDA Inspection 1159061 — Compound Preferred LLC

Compound Preferred LLC — FEI 3012465222

The FDA completed an inspection of Compound Preferred LLC on December 17, 2021 in Idaho Falls, ID. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
December 17, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Idaho Falls, ID (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
117421 CFR 211.42(b)Product flow through building is inadequate
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
143521 CFR 211.42(c)(10)(v)Cleaning System
145221 CFR 211.113(b)Validation lacking for sterile drug products
18953FDCA 501(a)(2)(A)Actionable microbial contamination, ISO 5 area
360321 CFR 211.160(b)Scientifically sound laboratory controls